Inclusion in the Cancer Drugs Fund will give more women in England and Wales with recurrent, platinum-sensitive ovarian cancer access to ZEJULA via a managed access arrangement ZEJULA was launched...
More From BioPortfolio on "TESARO, Inc.: TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK"